1. Home
  2. PGEN vs TSLX Comparison

PGEN vs TSLX Comparison

Compare PGEN & TSLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$6.25

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Sixth Street Specialty Lending Inc.

TSLX

Sixth Street Specialty Lending Inc.

HOLD

Current Price

$17.16

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGEN
TSLX
Founded
1998
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
2013
2011

Fundamental Metrics

Financial Performance
Metric
PGEN
TSLX
Price
$6.25
$17.16
Analyst Decision
Buy
Buy
Analyst Count
5
9
Target Price
$8.33
$21.61
AVG Volume (30 Days)
3.7M
488.7K
Earning Date
05-13-2026
05-05-2026
Dividend Yield
N/A
10.82%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$230,981,000.00
N/A
Revenue This Year
$1,115.92
N/A
Revenue Next Year
$81.04
$1.20
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.70
$16.04
52 Week High
$6.04
$24.79

Technical Indicators

Market Signals
Indicator
PGEN
TSLX
Relative Strength Index (RSI) 65.51 49.34
Support Level $3.96 $16.39
Resistance Level $6.04 $17.99
Average True Range (ATR) 0.31 0.44
MACD 0.04 0.03
Stochastic Oscillator 79.59 43.44

Price Performance

Historical Comparison
PGEN
TSLX

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

About TSLX Sixth Street Specialty Lending Inc.

Sixth Street Specialty Lending Inc is a specialty finance company focused on providing flexible, fully committed financing solutions to middle market companies located in the United States of America. The company partners with other companies across a variety of industries and provides creative solutions with complex business models that may have limited access to capital. The company seeks to generate current income in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine and unsecured loans and investments in corporate bonds and equity securities.

Share on Social Networks: